The Influence of Botulinum Toxin A Injections into the Calf Muscles on Genu Recurvatum in Children With Cerebral Palsy
- 1 July 2013
- journal article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 471 (7) , 2327-2332
Abstract
With cerebral palsy (CP), an equinus deformity may lead to genu recurvatum. Botulinum toxin A (BtA) injection into the calf muscles is a well-accepted treatment for dynamic equinus deformity. The purpose of this study was to determine whether BtA injections into the calf muscles to decrease equinus would decrease coexisting genu recurvatum in children with diplegic CP. In a retrospective study, 13 children (mean age, 5 years) with spastic diplegic CP showing equinus and coexisting primary genu recurvatum, who were treated with BtA injections into the calf muscles, were included. Evaluations were done before and 6 and 18 weeks after intervention using three-dimensional gait analysis and clinical examinations according to a standardized protocol. Basic statistical analyses (power analysis, ANOVA) were performed to compare genu recurvatum before treatment and at 6 and 18 weeks after injection with BtA. During stance phase, maximum ankle dorsiflexion was increased substantially from −3.0° ± 14.3° before to 6.2° ± 14.2° 6 weeks after the injections. Despite this, with the numbers available, the amount of recurvatum in stance did not improve with treatment at either 6 or 18 weeks. There was significant improvement of knee hyperextension during stance phase of 6.2° between baseline and 18 weeks after BtA injection, but a genu recurvatum was still present in most patients. Despite improvement of ankle dorsiflexion after injection with BtA, genu recurvatum did not show relevant improvement at 6 or 18 weeks after injection with the numbers available. Because knee hyperextension remained in most patients, other factors leading to genu recurvatum should be taken into consideration. In addition, a botulinum toxin-induced weakness of the gastrocnemius may explain why recurvatum gait was not significantly reduced. Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.Keywords
This publication has 39 references indexed in Scilit:
- Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: A randomized double-blind placebo controlled-trialJournal of Rehabilitation Medicine, 2011
- Muscle contributions to support and progression during single-limb stance in crouch gaitJournal of Biomechanics, 2010
- Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic reviewClinical Rehabilitation, 2010
- Treatment of spastic diplegia in patients with cerebral palsy: Part IIJournal of Pediatric Orthopaedics B, 2004
- Change of Dynamic Gastrocnemius and Soleus Muscle Length After Block of Spastic Calf Muscle in Cerebral PalsyAmerican Journal of Physical Medicine & Rehabilitation, 2002
- The Vulpius procedure for correction of equinus deformity in patients with hemiplegiaThe Journal of Bone and Joint Surgery. British volume, 2002
- Double‐blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsyDevelopmental Medicine & Child Neurology, 2002
- Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis studyGait & Posture, 1996
- Measurement of lower extremity kinematics during level walkingJournal of Orthopaedic Research, 1990
- Surgical Correction of Equinus Deformity in Cerebral PalsyDevelopmental Medicine & Child Neurology, 1980